Federal Register notice: FDA seeks comments on an information collection exetension for Medical Device Labeling Regulations 21 CFR parts 800, 801, an...
FDA accepts for review a Medicines360 supplemental NDA that seeks to extend the duration of use for preventing pregnancy from up to four years to up t...
FDA clears an Access Vascular 510(k) for the HydroPICC, a peripherally inserted central catheter, intended for long-term use.
Federal Register notice: FDA announces a 4/19 Peripheral and Central Nervous System Drugs Advisory Committee meeting.
FDA has accepted for filing a Medicines360 sNDA to increase the duration of use to prevent pregnancy of its Liletta hormone-releasing intrauterine sys...
PhRMA strongly opposes and AdvaMed strongly supports an FDA proposal for a devices referencing drugs regulatory pathway.
FDA posts a Web page linking to documents on its efforts to improve the predictability and consistency of the electronic submission process.
FDA clears a NeoTract 510(k) for new indications for the UroLift System to treat an enlarged prostate or benign prostatic hyperplasia.